Exosens Consolidates Its Brands Photonis, Xenics, and Telops Under a Single Banner
Exosens announced on Wednesday the gradual consolidation of all its brands under the Exosens umbrella. This change comes nearly two years after the group's IPO and continues its development since this pivotal milestone.
Unification of Multiple Technology Brands
Products currently marketed under the brands Photonis, Xenics, El-Mul, Telops, Noxant, Phasics, and Emberion will gradually transition to the Exosens brand. This unification aims to provide customers and partners with a simpler and more coherent understanding of the group's offerings, while allowing all products to benefit from the strength and reputation of the Exosens brand on an international scale.
Since its IPO, Exosens has increased its visibility in its markets and continued its growth strategy, both organically and through targeted acquisitions. The group has integrated technological expertise and developed a portfolio of solutions covering amplification, detection, and imaging.
Positioning in Critical Markets
This momentum has enabled the group to strengthen its positions in markets such as Defense, Nuclear, Life Sciences, and Industrial Control, while integrating teams, technologies, and complementary product portfolios. According to Paul Ryckaert, Chief Strategy Officer of Exosens, this step marks a new phase in the transformation of the group and affirms the coherence of its offering by bringing together the products under a single brand.
